PubMed

Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.

Kurzrock R, Blick MB, Talpaz M, Velasquez WS, Trujillo JM, Kouttab NM, Kloetzer WS, Arlinghaus RB, Gutterman JU.

Ann Intern Med. 1986 Nov;105(5):673-9.PMID: 3094418 [PubMed - indexed for MEDLINE]Related articles

The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.

Wiedemann LM, Karhi KK, Shivji MK, Rayter SI, Pegram SM, Dowden G, Bevan D, Will A, Galton DA, Chan LC.

Blood. 1988 Feb;71(2):349-55.PMID: 3276362 [PubMed - indexed for MEDLINE]Related articlesFree article

Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Rubin CM, Carrino JJ, Dickler MN, Leibowitz D, Smith SD, Westbrook CA.

Proc Natl Acad Sci U S A. 1988 Apr;85(8):2795-9.PMID: 2833755 [PubMed - indexed for MEDLINE]Related articlesFree article

Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.

Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers GJ, Van der Plas D, Grosveld G.

Genes Chromosomes Cancer. 1993 Dec;8(4):237-45.PMID: 7512367 [PubMed - indexed for MEDLINE]Related articles

Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.

Drexler HG, MacLeod RA, Uphoff CC.

Leuk Res. 1999 Mar;23(3):207-15. Review.PMID: 10071072 [PubMed - indexed for MEDLINE]Related articles

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

Hermans A, Heisterkamp N, von Linden M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G.

Cell. 1987 Oct 9;51(1):33-40.PMID: 2820585 [PubMed - indexed for MEDLINE]Related articles

Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.

Kurzrock R, Shtalrid M, Talpaz M, Kloetzer WS, Gutterman JU.

Blood. 1987 Nov;70(5):1584-8. Review.PMID: 3311207 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.

Aurich J, Duchayne E, Huguet-Rigal F, Bauduer F, Navarro M, Perel Y, Pris J, Caballin MR, Dastugue N.

Hematol Cell Ther. 1998 Aug;40(4):149-58.PMID: 9766919 [PubMed - indexed for MEDLINE]Related articles

Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.

van der Plas DC, Grosveld G, Hagemeijer A.

Cancer Genet Cytogenet. 1991 Apr;52(2):143-56. Review.PMID: 2021916 [PubMed - indexed for MEDLINE]Related articles

Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.

Kantarjian HM, Shtalrid M, Kurzrock R, Blick M, Dalton WT, LeMaistre A, Stass SA, McCredie KB, Gutterman J, Freireich EJ, et al.

Am J Med. 1988 Nov;85(5):639-44.PMID: 3189367 [PubMed - indexed for MEDLINE]Related articles

[Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia]

Bartram CR.

Onkologie. 1987 Jun;10(3):127-32. German. PMID: 3306531 [PubMed - indexed for MEDLINE]Related articles

Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.

Tosi S, Cabot G, Giudici G, Attuati V, Morandi P, Rambaldi A, Döhner H, Biondi A.

Cancer Genet Cytogenet. 1996 Jul 15;89(2):153-6.PMID: 8697423 [PubMed - indexed for MEDLINE]Related articles

Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.

Morris SW, Daniel L, Ahmed CM, Elias A, Lebowitz P.

Blood. 1990 May 15;75(10):2035-41.PMID: 2337672 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.

Jadayel D, Calabrese G, Min T, van Rhee F, Swansbury GJ, Dyer MJ, Maitland J, Palka G, Catovsky D.

Leukemia. 1995 Jun;9(6):981-7.PMID: 7596189 [PubMed - indexed for MEDLINE]Related articles

Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.

Brunel V, Sainty D, Costello R, Mozziconacci MJ, Simonetti J, Arnoulet C, Coignet L, Bouabdallah R, Gastaut JA, Gabert J, et al.

Cancer Genet Cytogenet. 1995 Nov;85(1):82-4.PMID: 8536245 [PubMed - indexed for MEDLINE]Related articles

Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene.

Bartram CR, Bross-Bach U, Schmidt H, Waller HD.

Blut. 1987 Dec;55(6):505-11.PMID: 3480009 [PubMed - indexed for MEDLINE]Related articles

[Molecular biology of chronic myeloid leukemia]

Hellmann A.

Acta Haematol Pol. 1992;23(2 Suppl 1):13-7. Review. Polish. PMID: 1488867 [PubMed - indexed for MEDLINE]Related articles

Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia.

De Klein A.

Mutat Res. 1987 Sep;186(2):161-72. Review.PMID: 3306360 [PubMed - indexed for MEDLINE]Related articles

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.

Huntly BJ, Bench AJ, Delabesse E, Reid AG, Li J, Scott MA, Campbell L, Byrne J, Pinto E, Brizard A, Niedermeiser D, Nacheva EP, Guilhot F, Deininger M, Green AR.

Blood. 2002 Jun 15;99(12):4547-53.PMID: 12036887 [PubMed - indexed for MEDLINE]Related articlesFree article

Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Steinberg M.

Clin Ther. 2007 Nov;29(11):2289-308. Review.PMID: 18158072 [PubMed - indexed for MEDLINE]Related articles